Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management.
CONCLUSION: Despite the fact that omeprazole is one of the most widely prescribed drugs internationally, clinical professionals should enhance clinical risk management on adverse DDIs associated with omeprazole and ensure safe combination use of omeprazole by rationally prescribing alternatives, checking the appropriateness of physician orders before dispensing, and performing therapeutic drug monitoring.
PMID: 23745048 [PubMed]
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Li W, Zeng S, Yu LS, Zhou Q Tags: Ther Clin Risk Manag Source Type: research
More News: Acid Reflux | Breast Cancer | Cancer | Cancer & Oncology | Carbamazepine | Clopidogrel | Diazepam | Dyspepsia | Gastric (Stomach) Cancer | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Ginkgo | Herbs | Methotrexate | Norvir | Omeprazole | Oral Cancer | Peptic Ulcer | Plavix | Prilosec | Prograf | Proton Pump Inhibitors PPIs | Tacrolimus | Toxicology | Valium